California-based Jeeter is the number one pre-roll brand in the country, according to Custom Cones USA’s first-ever Top 100 Pre-Roll Brands report. The report, developed with cannabis data firm Headset, used sales figures from 2024 in 13 state markets and found Jeeter sold more than 316 million units which equates to an 8% market share.
In a statement, Harrison Bard, CEO of Custom Cones USA, said, “Jeeter’s success story represents the evolution of pre-rolls from commodity products to premium experiences.”
“Their $245 million revenue – more than double their closest competitor – shows how innovation in infused products can create market leadership as their demand continues to grow.” — Bard in a press release
The report found that the top 10 pre-roll brands account for 21.5% of total U.S. pre-roll sales. California-based STIIIZY ranked second on the list with $110.5 million in sales, while Green Thumb Industries-owned Dogwalkers ranked third on the list with $77 million in sales. Michigan-based Cali-Blaze ranked fourth with $61.8 million in sales, while Presidential, which was founded by former professional basketball player Everett Smith, rounds out the top five with $43.3 million in sales.
California hosted 41 of the top 100 brands, although Michigan led in total unit sales. Michigan-based Dragonfly sold 12.3 million units – the most of any brand – but the average price of the company’s pre-rolls is $2.38, which lands the brand at number eight in the country with $29.3 million in sales.
Get daily cannabis business news updates.Subscribe
Have an additional perspective to share? Send us a message to let us know, and if your comment is chosen by our editors it could be featured here.
Perspective to add? Suggest a revision or submit commentary for review using the form below.
[PRESS RELEASE] – MUNDELEIN, Ill., June 17, 2025 –Terrabis, a leading multistate cannabis operator, announced its newest milestone with the approval to open its fifth Illinois dispensary. The new location in Mundelein will open its doors later this year, marking another significant step in the company’s strategic growth within the state’s thriving cannabis market.
The new store will be at 3210 W. Route 60 on Mundelein’s northwest side. Conveniently located within the bustling Mundelein Crossings shopping center, the site offers easy access for residents and visitors.
The upcoming dispensary in Mundelein will join Terrabis’ existing four dispensaries in Illinois, further solidifying the company’s presence in the Midwest. This milestone follows a period of remarkable growth for Terrabis, including the successful launch of its own Terrabis flower line earlier this year.
Over the past eight months, Terrabis has opened three new locations in Illinois, underlining its commitment to delivering a consistent and high-quality cannabis experience to customers. The Mundelein location will bring the Terrabis network to nine dispensaries across Illinois and Missouri.
“This achievement reflects our dedication to responsible expansion and delivering on our mission to create truly unique cannabis experiences,” Terrabis CEO Dan Ambrosino said. “Mundelein is an exciting addition to our portfolio of Illinois dispensaries, and we look forward to continuing our growth while maintaining our core values of community impact, exploration and wellness.”
Mundelein has long been recognized as playing a pivotal role in shaping Illinois’ cannabis culture. As Terrabis prepares to open its fifth Illinois dispensary in this influential town, the company is excited to contribute to the area’s growing reputation as a hub for cannabis innovation.
Terrabis’ continued Illinois expansion signals the company’s ongoing success and dedication to bolstering local communities by fostering economic development and job creation. The company is committed to driving ingenuity within the cannabis industry and setting a benchmark for operational excellence in dispensary management. By prioritizing community impact and industry leadership, Terrabis is creating lasting value for both its customers and the regions it serves.
Terrabis is a privately held, leading, multistate cannabis operator with a corporate office in Chicago. The company has dispensaries in Illinois and Missouri, with a product manufacturing facility in Kansas City, Mo.
The governor of Texas still hasn’t made a decision on a bill lawmakers recently sent to his desk that would ban consumable hemp products with any traces of THC—but he says there are “meaningful positions and concerns on both sides of the issue.”
As advocates and stakeholders continue to push for a veto of SB 3, which they say would effectively eradicate the hemp market in Texas, Gov. Greg Abbott (R) said on Monday that he has hundreds of bills to review and he “hasn’t gotten to” the cannabis legislation yet.
“I’ll tell you this: Listen, there are meaningful positions and concerns on both sides of the issue, and I’ll look into all of those and evaluate all of those,” he told reporters during a Q & A session following a bill signing ceremony for an unrelated measure.
“I will give all of those pieces of legislation the consideration and time that they deserve,” the governor said at the time, while sitting beside one of the measure’s most vocal supporters, Lt. Gov. Dan Patrick (R).
But it’s notable that, in his latest comments, he seemed to acknowledge that supporters and opponents of the measure have “meaningful” arguments that he’s taking into account.
The governor has three options for the proposal: sign it, veto it or allow it to take effect without his signature. The deadline for his decision is this Sunday, June 22.
Last month, a spokesperson for the governor separately declined to disclose Abbott’s plan for the bill, saying only that he “will thoughtfully review any legislation sent to his desk.”
Texas lawmakers legalized the sale of consumable hemp in 2019, following enactment of the 2018 federal Farm Bill, which legalized the plant nationwide. That’s led to an explosion of products—including edibles, drinks, vape products and cured flower—sold by an estimated 8,000 retailers.
Abbott separately signed a bill into law last week to create a state-backed research consortium to conduct clinical trials on ibogaine as a possible treatment for substance use disorders and other mental health conditions. The ultimate goal of the project is to develop the psychedelic into a prescription drug with federal Food and Drug Administration (FDA) approval, with the state retaining a portion of the profit.
The measure would expand the state’s list of medical cannabis qualifying conditions to include chronic pain, traumatic brain injury (TBI), Crohn’s disease and other inflammatory bowel diseases, while also allowing end-of-life patients in palliative or hospice care to use marijuana.
Under the proposal, state law would be amended to say that local entities “may not place an item on a ballot, including a municipal charter or charter amendment, that would provide that the local entity will not fully enforce” state drug laws.
While several courts have previously upheld local cannabis decriminalization laws, an appellate court comprised of three conservative justices appointed by the governor has recently pushed back against two of those rulings, siding with the state in its legal challenge to the marijuana policy in Austin and San Marcos.
Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Some cannabis strains can bring on the munchies – so this business pairing in a great combo for consumers!
In a cannabis match made in Heaven, cannabis dispensary giant Planet 13 announced they will share a building with Taco Bell in Edgewater, Florida (Daytona Beach area). It seems like real estate genius to place the two businesses next to each other.
“A true match made in cannabis heaven!” says Jeffrey Trappe, Chief Operating Officer Florida Operations of Planet 13.
Taco Bell and marijuana have a relationship that’s become something of a cultural cliché—and for good reason. According to a 2017 study, Taco Bell was more than twice as popular as any other fast food chain when it came to satisfying the cravings of cannabis consumers. That’s not just brand loyalty—that’s next-level munchies magic.
There’s something uniquely satisfying about Taco Bell’s menu when you’re high. Maybe it’s the savory-soft-crunch of a Doritos Locos Taco, or the customizable chaos of a Crunchwrap Supreme. Add to that the fact that most locations are open late, and you’ve got the perfect storm for a stoner’s snack attack.
Taco Bell’s genius lies in its mashup-style food: bold flavors, textures, and combinations that somehow make perfect sense to a cannabis-influenced palate. High customers crave novelty and indulgence, and Taco Bell delivers both with every cheesy, spicy bite. It’s no wonder the chain leads the pack as the preferred pit stop for those feeling elevated and hungry.
But here’s a twist: not all marijuana makes you hungry. Some strains—particularly sativa-dominant ones—can actually suppress appetite or increase focus and creativity without prompting a fridge raid. The “munchies” typically come from strains higher in THC, which interact with the brain’s endocannabinoid system, increasing your desire for food.
Still, for millions of cannabis users, lighting up and hitting up Taco Bell is practically a ritual. Whether you’re diving into a late-night Quesarito or crafting a $20 custom feast via the app, Taco Bell meets the moment—and the munchies—with open arms and a loaded value menu.
In a post-legalization world where cannabis culture is going mainstream, Taco Bell sits comfortably at the intersection of fast food and faded cravings. For better or worse, when the buzz hits, the Bell often rings loudest and Planet 13 joins in the happy noise.